STG-175

N/A

Report date: 2022/09/09 14:09:25
NME

Base Information

Drug NameSTG-175
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclophilins inhibitors
TargetsCyclophilins
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesS & T Global Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesS & T Global Inc
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A